Silvia Bio raises £3 million in seed funding with backing from Parkwalk fund

Silvia Bio raised £3 million in seed funding in a round led by Northern Gritstone. Parkwalk’s Northern Universities Venture Fund participated in the round. Other investors included the UK Innovation & Science Seed Fund, managed by Future Planet Capital, Wren Capital and angel investors. The University of Sheffield biotechnology spinout develops cell-profiling technology and additives to improve manufacturing yields and quality for complex biological medicines. Funding will support tripling headcount, automating processes and developing licensable products as Silvia Bio expands internationally. Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Parkwalk Advisors Ltd published the original content used to generate this news brief on October 15, 2026, and is solely responsible for the information contained therein. (C)